MedPath

The role of androgens in sexual functioning of women with primary ovarian insufficiency: a comparative cross-sectional study

Completed
Conditions
premature menopause
seksuele functie- en fertiliteitsstoornissen
Premature ovarian failure (POF)
10033283
10014701
Registration Number
NL-OMON41190
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
174
Inclusion Criteria

- POI patient
- Being treated for POI
- Aged 18 - 39
- Understanding of Dutch language
- Able and willing to provide informed consent
- In a relationship (>3 months)
- Control groups should be using one of the following birth control methods: the second, third or fourth generation pill or Mirena intra uterine device

Exclusion Criteria

- Oophorectomy or radiation of the ovaries
- Androgen therapy during the six months prior to study start
- Lactation and/or pregnancy in the six months prior to study start
- Subjects experiencing relational discord as indicated by a score of >= 20 on the MMQ-M
- Other birth-control methods than described at inclusion criteria or no birth-control
- Chronic disease

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>1. Hormone determinations:<br /><br>- FSH<br /><br>- 17-ß estradiol<br /><br>- total testosterone<br /><br>- SHBG<br /><br>- Free testosterone (calculated with Free Androgen Index (FAI): [total<br /><br>testosterone] / [SHBG] x 100)<br /><br>- DHEA<br /><br><br /><br>2. Genital response measured as VPA during:<br /><br>- self-induced erotic fantasy<br /><br>- watching sexual stimuli (erotic film)<br /><br>- at baseline<br /><br><br /><br>3. Subjective genital response determined by questions about:<br /><br>- overall feeling of sexual arousal<br /><br>- strongest feeling of sexual arousal<br /><br>- strongest genital sensation<br /><br>- amount of vaginal lubrication<br /><br><br /><br>4. Implicit associations respective to sexual stimuli by measuring reaction<br /><br>times</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Questionnaires: FSFI, FSDS-R, MMQ</p><br>
© Copyright 2025. All Rights Reserved by MedPath